Research Areas

DCP supports and funds the discovery, development, and testing of innovative approaches for cancer prevention, detection, and symptom management.

• Prevention and Interception
• Screening and Detection
• Symptom Science and Cancer Care
• Areas of Research Interest
• Funded Grants Search

DCP clinical trials networks support human research in cancer prevention, cancer detection, and symptom management for cancer patients.

• NCI Community Oncology Research Program (NCORP)
• Cancer Screening Research Network (CSRN)
• Cancer Prevention Clinical Trials Network (CP-CTNet)
• HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network
• NCI Cervical Cancer ‘Last Mile’ Initiative
• US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)

Biomarker development research seeks to identify and measure biologic signals and create validated tools to improve cancer prevention and detection.

• Early Detection Research Network (EDRN)
• Liquid Biopsy Consortium
• Pancreatic Cancer Detection Consortium (PCDC)
• Pre-Cancer Atlas (PCA)
• See All Networks

Cancer prevention agent discovery and development includes in vitro and in vivo studies to evaluate agent efficacy, toxicity, and potential new biomarkers.

• Cancer Immunoprevention Network (CIP-Net)
• Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT)
• Discovery and Development of Natural Products for Cancer Interception and Prevention (DDNP-CIP)
• Prevent Cancer Preclinical Drug Development Program (PREVENT)